Show simple item record

dc.contributor.authorTaylor, Rod S.
dc.contributor.authorElston, J
dc.date.accessioned2013-07-04T12:32:48Z
dc.date.issued2009-01
dc.description.abstractTo explore the use of surrogate outcomes in Health Technology Assessment (HTA) and provide a basis for guidance for their future use, validation and reporting. This report focuses on the role of surrogate outcomes in cost-effectiveness models (CEMs) within UK HTA Programme reports.en_GB
dc.identifier.citationHealth Technology Assessment, 2009, Vol. 13, Issue 8, pp. iii - 50en_GB
dc.identifier.doi10.3310/hta13080
dc.identifier.urihttp://hdl.handle.net/10871/11532
dc.language.isoenen_GB
dc.publisherNIHR Health Technology Assessment Programmeen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/19203465en_GB
dc.relation.urlhttp://www.journalslibrary.nihr.ac.uk/hta/volume-13/issue-8en_GB
dc.subjectBiological Markersen_GB
dc.subjectCost-Benefit Analysisen_GB
dc.subjectData Interpretation, Statisticalen_GB
dc.subjectEvidence-Based Medicineen_GB
dc.subjectHealth Policyen_GB
dc.subjectHumansen_GB
dc.subjectOutcome Assessment (Health Care)en_GB
dc.subjectProportional Hazards Modelsen_GB
dc.subjectQuality-Adjusted Life Yearsen_GB
dc.subjectReproducibility of Resultsen_GB
dc.subjectTechnology Assessment, Biomedicalen_GB
dc.titleThe use of surrogate outcomes in model-based cost-effectiveness analyses: a survey of UK Health Technology Assessment reports.en_GB
dc.typeArticleen_GB
dc.date.available2013-07-04T12:32:48Z
exeter.place-of-publicationEngland
dc.descriptionaddresses: Peninsula Technology Assessment Group (PenTAG), Peninsula Medical School, Universities of Exeter and Plymouth, UK.en_GB
dc.descriptiontypes: Journal Article; Reviewen_GB
dc.descriptionPublished version. Copyright © 2009 NIHR Health Technology Assessment Programmeen_GB
dc.identifier.journalHealth Technology Assessmenten_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record